New CBO Study Compares Net Prices for Brand-Name Drugs Among Federal Programs, Finds Medicaid Gets Largest Discounts

In a new groundbreaking study, the Congressional Budget Office compared brand-name drug prices, net of rebates and discounts, across select federal programs and agencies including Medicaid, Medicare Part D and the Department of Veterans Affairs (VA).  It found that Medicaid gets the lowest net prices, far below that of Medicare Part D plans and well […]

Medicaid Expansion’s Effects on Families: More coverage, improved maternal health, better preventive care

We’ve been tracking the rates of uninsured children for more than a decade now, and after reaching an all-time low in 2016 nationwide, the number started going in the wrong direction over the past three years. From 2016 to 2019 approximately 726,000 more children became uninsured. The report we released today looks more closely at […]

House Energy and Commerce Committee Reconciliation Legislation Would Spur Medicaid Expansion and Promote Maternal Health

The House Energy and Commerce Committee has unveiled its portion of the House COVID-19 relief reconciliation bill, with a markup of the Committee’s recommendations scheduled for Thursday, February 11, 2021.  Several of the Energy and Commerce Committee’s reconciliation provisions strengthen Medicaid and the Children’s Health Insurance Program (CHIP), including provisions to encourage states to finally […]

House Energy and Commerce Committee Reconciliation Legislation Includes Sound Medicaid Drug Rebate Provision

Last night, the House Energy and Commerce Committee unveiled its recommendations for the House COVID-19 relief reconciliation bill, with a markup scheduled for February 11, 2021.  One sound Medicaid provision would, as of January 1, 2023, eliminate the current cap on total drug rebates that manufacturers must pay state Medicaid programs, which would produce significant […]